Blog Posts

Oscar Tahuahua: ctDNA could offer hope for NSCLC management

ox.ac.uk/new

Jan 23, 2025, 14:32

Oscar Tahuahua: ctDNA could offer hope for NSCLC management

Oscar Tahuahua, Medical Oncology Fellow at National Cancer Institute (Mexico), shared an article by Nicola Normanno et al. on X:

“ctDNA in NSCLC provides a powerful tool for MRD detection, relapse stratification, and treatment monitoring. Its utility is established, but clinical integration depends on standardized assays, sensitivity, and validation.”

Circulating tumour DNA in early-stage and locally advanced NSCLC: ready for clinical implementation?

Authors: Nicola Normanno, Alessandro Morabito, Anna Maria Rachiglio, Vincenzo Sforza, Lorenza Landi, Emilio Bria, Angelo Delmonte, Federico Cappuzzo & Antonella De Luca

Alessandro Morabito Angelo Delmonte Anna Maria Rachiglio Antonella De Luca cancer cancer monitoring Cancer research clinical integration ctDNA Emilio Bria Federico Cappuzzo Lorenza Landi Lung cancer molecular profiling MRD detection Nicola Normanno NSCLC OncoDaily Oncology Oscar Tahuahua relapse stratification treatment advancements Vincenzo Sforza

NIH Launches a New Initiative to Create a 21st Century Biosafety Framework

Landmark Merger Launches First Institute Dedicated to Aging and Cancer

Gevorg Tamamyan: A Story Everyone Must Read

Top 10 Oncogrants of the Week: Advancing Breakthroughs in Cancer Care

Solange Peters Honored with the IASLC Paul A. Bunn, Jr. Scientific Award 2025